AlphAIalphai — Financial news for AI agents
Seeking AlphaMAY 72 min read$KRMD

KORU Medical Systems, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:KRMD) 2026-05-07

KORU Medical Systems, Inc. (NASDAQ:KRMD) published its slide deck in conjunction with its 2026 Q1 earnings call. This presentation provides details discussed during the call for investors and interested parties. The content was prepared by Seeking Alpha's transcripts team.

Original reporting
Seeking Alpha · SA Transcripts
Published May 7, 2026, 2:40 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 7, 2026, 3:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefFinancial news
Primary signal
$KRMD
Neutral
medium confidence
Mentioned
$KRMD
alphai data visualization · based on Seeking Alpha
Decision brief

The 30-second read

$KRMDNeutralLow
01

Why it matters

The earnings call suggests stable performance, with no immediate catalysts for significant price movement.

02

Market read

The news is relevant for investors holding or considering KORU Medical Systems stock but has limited impact on broader market indices.

03

What to watch

Potential upcoming product launches or regulatory approvals not discussed in the presentation could influence future performance.

Timing: Immediate, as earnings are recent and publicly available.

Background

KORU Medical Systems specializes in medical devices, with earnings reflecting its financial health and market position.

Company-level read

Ticker impact

$KRMDNeutralMedium confidence
Context

The news pertains directly to KORU Medical Systems, Inc., providing detailed financial results and investor information.

Expected impact

Minimal immediate price movement expected; potential for slight volatility around earnings release date.

Evidence & confidence

The neutral sentiment and lack of major surprises suggest limited short-term price impact, though investor reactions could vary.

Market effects

Sector

The results may influence perceptions of the medical device sector's stability but are unlikely to cause sector-wide shifts.

Regional

Limited regional impact, as the company is US-based and the news is specific to its earnings.

Global

Low; the company's performance is not a major driver of global markets.

Counterpoint

What could challenge this read

Positive surprise in future quarters could lead to upward revisions; current neutral stance may overlook potential growth catalysts.

Key entities

  • Company
    KORU Medical Systems, Inc.

    A medical device company focused on blood collection and infusion devices.

Read at source← All news

Related articles

AUG 7
$KRMDMed

KORU Medical Systems Q2 Earnings Call Highlights

KORU Medical Systems (KRMD) reported Q2 PST revenue of $0.6M, down 35% year over year, citing lower clinical-trial orders and timing. Gross margin rose to 65.1% from 63.5%. The company narrowed full-year revenue guidance to $47.5M-$48.5M, raised gross-margin guidance to 62%-64%, ended with $8.3M cash, and expects positive adjusted EBITDA. It acquired a connected monitoring technology asset and shifted some FDA oncology timing.

yahoo.com7 min
AUG 7
$KRMDMedAI 8/10

KORU Medical Systems, Inc. Q2 2026 Earnings Call Summary

KORU Medical Systems reported Q2 2026 revenue up 18% and first positive net income since 2019, with domestic revenue up 12% and international revenue up 59%. It withdrew a US FDA 510(k) for Phesgo, narrowed FY revenue guidance to $47.5M-$48.5M, raised gross margin to 62%-64%, and expects positive adjusted EBITDA in 2026.

yahoo.com7 min
AUG 5
$KRMDMed

KORU Medical Systems, Inc. (KRMD): Results of Operations and Financial Condition

KORU Medical Systems, Inc. (KRMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 ex_99-1.htm PRESS RELEASE, DATED AUGUST 5, 2026 EXHIBIT 99.1 KORU Medical Systems Announces Second Quarter 2026 Results and Updates Full Year 2026 Guidance MAHWAH, NJ – August 5, 2026 – KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading

SEC EDGAR 8-K6 min
AUG 8
$SUNEMedAI 8/10

Pentagon to invest $400m in Australian rare earth mine

Sunrise Energy Metals said the US Pentagon will provide a conditional $400 million loan commitment to develop Syerston, a proposed scandium mine in Fifield, NSW. The project targets Western supply of scandium used in defence and other sectors amid China’s export restrictions. Sunrise also said it has a deal with Lockheed Martin for 25% of output for five years.

bssnews.net4 min
AUG 8
$WTRGMed

Trump administration to invest $3 billion in minerals projects to boost US defence supply chains

President Trump said the US will invest $3 billion in critical minerals and battery projects to expand domestic supply chains for national security. He announced Defence Department Office of Strategic Capital conditional loans totaling $1.4B to Sila Nanotechnologies, $400M to Sunrise Energy Metals, and $150M to Niron Magnetics, plus $58M Export-Import Bank loans. The plan also includes $100M in mining-school grants and $80M for three schools.

tribune.com.pk6 min
AUG 8
$NVDAMed

Nvidia to Invest Up to $3 Billion in Blackstone

The Information reported Nvidia plans to invest up to $3 billion in Lancium, a Blackstone-backed power and data center infrastructure developer tied to the Stargate AI initiative. Nvidia would initially put in $2 billion for a 20% stake, with up to $1 billion more contingent on performance thresholds. No company comment was provided.

econotimes.com4 min
KORU Medical Systems, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:KRMD) 2026-05-07 — alphai